185 related articles for article (PubMed ID: 32613874)
1. Hepatitis c virus and chronic kidney disease.
Khan MU; Mahmoud MI; Butt AA
Expert Rev Gastroenterol Hepatol; 2020 Jul; 14(7):579-590. PubMed ID: 32613874
[TBL] [Abstract][Full Text] [Related]
2. [Direct-acting antiviral agents, hepatitis C and dialysis: an update].
Fabrizi F; Lampertico P; Messa P
G Ital Nefrol; 2018 Sep; 35(5):. PubMed ID: 30234230
[TBL] [Abstract][Full Text] [Related]
3. Generic sofosbuvir-based direct-acting antivirals in hepatitis C virus-infected patients with chronic kidney disease.
Manoj Kumar ; Nayak SL; Gupta E; Kataria A; Sarin SK
Liver Int; 2018 Dec; 38(12):2137-2148. PubMed ID: 29676846
[TBL] [Abstract][Full Text] [Related]
4. Direct-acting antivirals for hepatitis C virus in patients on maintenance dialysis.
Fabrizi F; Donato FM; Messa P
Int J Artif Organs; 2017 Oct; 40(10):531-541. PubMed ID: 28708211
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus infection in chronic kidney disease: paradigm shift in management.
Kim SM; Song IH
Korean J Intern Med; 2018 Jul; 33(4):670-678. PubMed ID: 29961309
[TBL] [Abstract][Full Text] [Related]
6. Chronic hepatitis C and chronic kidney disease: Advances, limitations and unchartered territories.
Mendizabal M; Reddy KR
J Viral Hepat; 2017 Jun; 24(6):442-453. PubMed ID: 28107583
[TBL] [Abstract][Full Text] [Related]
7. Management of hepatitis C in patients with chronic kidney disease.
Carvalho-Filho RJ; Feldner AC; Silva AE; Ferraz ML
World J Gastroenterol; 2015 Jan; 21(2):408-22. PubMed ID: 25593456
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C Treatment in Chronic Kidney Disease Patients: The Kidney Disease Improving Global Outcomes Perspective.
Jadoul M; Martin P
Blood Purif; 2017; 43(1-3):206-209. PubMed ID: 28114144
[TBL] [Abstract][Full Text] [Related]
9. Evolving therapies for hepatitis C virus in chronic kidney disease: the beginning of a new era.
Gordon CE; Nader C
Curr Opin Nephrol Hypertens; 2017 Mar; 26(2):129-135. PubMed ID: 27906748
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis C virus infection and chronic kidney disease: Time for reappraisal.
Cacoub P; Desbois AC; Isnard-Bagnis C; Rocatello D; Ferri C
J Hepatol; 2016 Oct; 65(1 Suppl):S82-S94. PubMed ID: 27641990
[TBL] [Abstract][Full Text] [Related]
11. New treatment for hepatitis C in chronic kidney disease, dialysis, and transplant.
Fabrizi F; Martin P; Messa P
Kidney Int; 2016 May; 89(5):988-994. PubMed ID: 27083277
[TBL] [Abstract][Full Text] [Related]
12. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).
Minutolo R; Aghemo A; Chirianni A; Fabrizi F; Gesualdo L; Giannini EG; Maggi P; Montinaro V; Paoletti E; Persico M; Perticone F; Petta S; Puoti M; Raimondo G; Rendina M; Zignego AL; ; ; ;
J Nephrol; 2018 Oct; 31(5):685-712. PubMed ID: 30255440
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Hepatitis C Virus Infection in Dialysis Patients.
Kikuchi K
Contrib Nephrol; 2018; 196():119-122. PubMed ID: 30041215
[TBL] [Abstract][Full Text] [Related]
14. High rate of acute kidney injury in patients with chronic kidney disease and hepatitis C virus genotype 4 treated with direct-acting antiviral agents.
Elmowafy AY; El Maghrabi HM; Mashaly ME; Eldahshan KF; Rostaing L; Bakr MA
Int Urol Nephrol; 2019 Dec; 51(12):2243-2254. PubMed ID: 31612423
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C in Chronic Kidney Disease: An Overview of the KDIGO Guideline.
Awan AA; Jadoul M; Martin P
Clin Gastroenterol Hepatol; 2020 Sep; 18(10):2158-2167. PubMed ID: 31376491
[TBL] [Abstract][Full Text] [Related]
16. Management of hepatitis C virus infection in patients with chronic kidney disease: position statement of the joint committee of Italian association for the study of the liver (AISF), Italian society of internal medicine (SIMI), Italian society of infectious and tropical disease (SIMIT) and Italian society of nephrology (SIN).
Minutolo R; Aghemo A; Chirianni A; Fabrizi F; Gesualdo L; Giannini EG; Maggi P; Montinaro V; Paoletti E; Persico M; Perticone F; Petta S; Puoti M; Raimondo G; Rendina M; Zignego AL;
Dig Liver Dis; 2018 Nov; 50(11):1133-1152. PubMed ID: 30266305
[TBL] [Abstract][Full Text] [Related]
17. HCV treatment initiation in persons with chronic kidney disease in the directly acting antiviral agents era: Results from ERCHIVES.
Butt AA; Ren Y; Puenpatom A; Arduino JM; Kumar R; Abou-Samra AB
Liver Int; 2018 Aug; 38(8):1411-1417. PubMed ID: 29271562
[TBL] [Abstract][Full Text] [Related]
18. HEPATITIS C TREATMENT OF RENAL TRANSPLANT AND CHRONIC KIDNEY DISEASE PATIENTS: EFFICACY AND SAFETY OF DIRECT-ACTING ANTIVIRAL REGIMENS CONTAINING SOFOSBUVIR.
Michels FBL; Amaral ACC; Carvalho-Filho RJ; Vieira GA; Souza ALDS; Ferraz MLG
Arq Gastroenterol; 2020; 57(1):45-49. PubMed ID: 32294735
[TBL] [Abstract][Full Text] [Related]
19. The effect of anemia on the efficacy and safety of treating chronic hepatitis C infection with direct-acting antivirals in patients with chronic kidney disease.
Elmowafy AY; Abbas MH; Denewar AA; Mashaly ME; Shiha G; El Wasif SM; Rostaing L; Bakr MA
Int Urol Nephrol; 2021 Apr; 53(4):749-761. PubMed ID: 33111161
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C virus and the kidney.
Pol S; Parlati L; Jadoul M
Nat Rev Nephrol; 2019 Feb; 15(2):73-86. PubMed ID: 30455426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
